GlassScriptPhysician profile
Marcy B Dillon
NPI 1851356125
$759.68
in general payments reported to CMS, 2019-2025
18 companies · $223 in 2025
The $223 reported for 2025 was more than what 77% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $24.32 · 2021: $111 · 2022: $165 · 2023: $109 · 2024: $128 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $89.49 | 2021-2024 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Sanofi Pasteur INC. | $84.77 | 2022-2025 | |
| Glaxosmithkline, LLC. | $63.48 | 2022-2025 | Bexsero, Penmenvy, Rotarix |
| Qol Medical, LLC | $59.49 | 2022 | |
| Alk-Abello, INC | $56.39 | 2025 | Grastek, Odactra, Neffy |
| Takeda Pharmaceuticals U.S.A., INC. | $54.81 | 2020-2021 | |
| Pfizer INC. | $54.07 | 2024-2025 | |
| Cumberland Pharmaceuticals, INC. | $50.20 | 2023 | Kristalose |
| Kaleo, INC. | $36.83 | 2021 | |
| Sanofi-Aventis U.S. LLC | $35.14 | 2024 | |
| Abbvie INC. | $25.31 | 2021 | |
| Collegium Pharmaceutical, INC. | $24.91 | 2025 | Jornay Pm |
| Vertical Pharmaceuticals, LLC | $23.20 | 2024 | Relexxii |
| Ars Pharmaceuticals Operations, INC. | $22.87 | 2025 | Neffy |
| Ultragenyx Pharmaceutical INC. | $22.75 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $20.24 | 2023 | Ycanth |
| Cognoa, INC. | $18.68 | 2022 | |
| Photonicare INC | $17.05 | 2025 | Otosight Middle Ear Scope |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcy Dillon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.